Journal profile · Biotechnology & Applied Microbiology
Gene Expression
ISSN 1555-3884 · Xia & He Publishing Inc. · USA · 4 issues a year · Founded 1991
Gene Expression: fully open access; APC about USD 980; review over 12 weeks (community reports); community-reported acceptance: 11%; 24 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Gene Expression is published by Xia & He Publishing Inc.. By OpenAlex counts of its recent articles, its largest topics are Liver physiology and pathology, Genomics and Chromatin Dynamics and Liver Disease Diagnosis and Treatment, together about 30.9% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Gene Expression is an open-access journal dedicated to publishing research at the intersection of science, biology, and medicine. The journal’s mission is to advance human health by providing a platform for disseminating the latest research breakthroughs from biomedical, translational, and basic scientists across both established and emerging disciplines relevant to human translational biomedicine. It was launched in 1991 by Chicago Medical School Press and transferred to Cognizant Communication Corporation in 1994. Since August 2022, Gene Expression has been published by Xia & He Publishing Inc. Gene Expression publishes peer-reviewed, high-quality original articles, reviews, editorials, commentaries, and opinions on core research topics, including cell biology, molecular biology, genes, and genetics, with a particular focus on the cellular and molecular mechanisms underlying human diseases, specifically in areas such as cardiovascular disease, immunology and vaccines, metabolism, diabetes and obesity, neuroscience, cancer, infectious diseases, aging, biomarkers, gene and cellular therapy, animal models of human diseases, medical integrative omics analysis, epigenetics and regulatory RNAs, and other interdisciplinary approaches.
Source: LetPub
Research area (LetPub): Biotechnology & Applied Microbiology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Liver physiology and pathologyMedicine16.6%
- Genomics and Chromatin DynamicsBiochemistry, Genetics and Molecular Biology7.7%
- Liver Disease Diagnosis and TreatmentMedicine6.6%
- Hepatocellular Carcinoma Treatment and PrognosisMedicine5.4%
- Developmental Biology and Gene RegulationBiochemistry, Genetics and Molecular Biology5.2%
- Drug-Induced Hepatotoxicity and ProtectionPharmacology, Toxicology and Pharmaceutics5.2%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology4.8%
- RNA Research and SplicingBiochemistry, Genetics and Molecular Biology3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Genetics | Q3 | 268/357 | 25th |
| Molecular Biology | Q4 | 334/414 | 19th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 2.6LetPub ·
- SJR 2026-06
- 0.32LetPub ·
- SNIP 2026-06
- 0.34LetPub ·
- h-index
- 43LetPub ·
- h-index
- 49OpenAlex ·
- i10-index
- 193OpenAlex ·
- 2-year mean citedness
- 1.59OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year
- 5LetPub ·
Articles by year OpenAlex count · 403 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 18 | 18 | 474 |
| 2025 | 24 | 24 | 732 |
| 2024 | 38 | 38 | 815 |
| 2023 | 46 | 46 | 754 |
| 2022 | 10 | 10 | 763 |
| 2021 | 5 | 5 | 774 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- 11%LetPub ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | USD 980 / USD 650 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
- Not considered
- preprint
Article types accepted12, with length limits
- editorial, beginning with “Dear Editor(s),” ~ 10 Editorial ~ 1 ~ 1000 words; Unstructured ~ 10 Opinion ~ 2 ~ 1500 words; Unstructured ~main text ≤ 1,000 words · figures and tables ≤ 1 · references ≤ 10
- hypothesisPlease ensure that any manuscript you submit to GE conforms to the recommendations for ethics of the Committee on Publication Ethics (COPE) and the Internationa…Length not stated
- letterPlease ensure that any manuscript you submit to GE conforms to the recommendations for ethics of the Committee on Publication Ethics (COPE) and the Internationa…main text ≤ 1,500 words
- letter to the editorPlease ensure that any manuscript you submit to GE conforms to the recommendations for ethics of the Committee on Publication Ethics (COPE) and the Internationa…Length not stated
- letters to the editorLetters to the Editor should describe timely issues related to a previous publication. These letters should use constructive and professional comments to expand…main text ≤ 800 words · figures and tables ≤ 1 · references ≤ 10
- meta-analysisPlease ensure that any manuscript you submit to GE conforms to the recommendations for ethics of the Committee on Publication Ethics (COPE) and the Internationa…Length not stated
- opinionial ~ 1 ~ 1000 words; Unstructured ~ 10 Opinion ~ 2 ~ 1500 words; Unstructured ~ 20 *Word count includes the main body of thmain text ≤ 1,500 words · figures and tables ≤ 2 · references ≤ 20
- original articleOriginal research manuscripts should describe experimental and/or clinical studies in biomedicine, including exploratory and hypothesis-driven studies of basic …main text ≤ 5,000 words · figures and tables ≤ 8 · references ≤ 50
- original researchPlease ensure that any manuscript you submit to GE conforms to the recommendations for ethics of the Committee on Publication Ethics (COPE) and the Internationa…Length not stated
- research letterResearch Letter ~ 3 ~ 1500 words; Unstructured~ 20Length not stated
- reviewPlease ensure that any manuscript you submit to GE conforms to the recommendations for ethics of the Committee on Publication Ethics (COPE) and the Internationa…main text ≤ 3,000 words · figures and tables ≤ 10 · references ≤ 300
- systematic reviewA systematic review paper, as defined by the Cochrane Collaboration, is a review of a clearly formulated question that uses explicit, systematic methods to iden…main text ≤ 5,000 words · figures and tables ≤ 8 · references ≤ 70
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Plagiarism, Preprints, Self-archiving, Trial registration / reporting guidelines
- AI use Use of AI Tools by Reviewers
Manuscripts under review are confidential. Reviewers must not upload unpublished manuscripts, figures, tables, supplementary files, review reports, or any confidential manuscript-related information to public AI platforms.
Source ↗Publisher website ·- Authorship Author Contributions
The Authors’ Contributions should be provided in paragraph form following the authors’ names and affiliations and corresponding author(s)’ information. The manner in which each author was involved with the study or preparation of the manuscript is listed with the author’s name (shown as initials, within parentheses). Contributions that are acceptable for inclusion as an author are: study design, p…
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest
All authors must check the ICMJE’s unified disclosure form. Each author should check the form to disclose any potential conflict of interest and is responsible for the accuracy and completeness of the provided information. The ICMJE’s form can be downloaded here.
Source ↗Publisher website ·- Data availability Data Sharing Statement
A Data Sharing Statement is required for research articles through which readers will know how to access the shared data. Sample wording: The [TYPE, such as technical appendix, statistical code, or dataset] data used to support the findings of this study have been deposited in the [NAME] repository ([DOI or other persistent identifier]); The [TYPE] data used to support the findings of this study a…
Source ↗Publisher website ·- Publication ethics
Plagiarism screening via Crossref Similarity Check Model summary
All submitted manuscripts will be checked using plagiarism detection software (Crossref Similarity Check).
Source ↗Publisher website ·- License & copyright Copyright
Starting from 2022, the copyright on all published articles will be retained with the authors unless stated otherwise. Authors grant GE the sole, worldwide, and exclusive right to publish (i.e., print, publish, sell, and otherwise commercially exploit), reproduce, display, and store the published articles.
Source ↗Publisher website ·- Open access
Open access under CC BY-NC 4.0 Model summary
Gene Expression (GE) adopts open access publishing model, and all articles are distributed under the terms of the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).
Source ↗Publisher website ·- Peer review Peer Review & Editorial Process
Single blind peer review Model summary
The objective of the peer review process is to ensure the integrity and transparency of the research objectives, data, and conclusions.Editorial ProcessAll manuscripts, solicited and unsolicited, that are submitted to GE will be subject to the following single blind peer review process, meaning that the author does not know the identity of the reviewer, but the reviewer knows the identity of the a…
Source ↗Publisher website ·- Plagiarism Types of Plagiarism
Plagiarism is defined by the GE as the use of information, including textual descriptions, figures/tables and data, from a previously published document without proper citation or reference to the original source. All submitted manuscripts will be checked using plagiarism detection software (Crossref Similarity Check).
Source ↗Publisher website ·- Preprints Preprint version
A preprint is the version of an article before peer-review. Authors are not requested to remove a preprint from a not-for-profit preprint server before submission. Upon acceptance, we recommend including an acknowledgment of acceptance on the first page, as follows:
Source ↗Publisher website ·- Self-archiving Self-archiving Policy
Authors of articles published in GE are permitted to self-archive the preprint version of the article at any time, and may self-archive the postprint and published version without embargo.
Source ↗Publisher website ·- Trial registration / reporting guidelines Study Reporting Guidelines
To enhance the quality and transparency of health research, GE requires all investigators to prepare articles according to appropriate EQUATOR research reporting guidelines. Each submission of an original article/systematic review/meta-analysis/case report/study protocol should be accompanied by an appropriate checklist as listed below. Authors can find more guidelines at EQUATOR and should indica…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Xia & He Publishing Inc.
- Country or region
- USA
- Language
- English
- Frequency
- 4 issues a year
- Founded
- 1991
- ISSN
- 1555-3884
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Gene Expression
How long does peer review take at Gene Expression?
Authors report an average review time of over 12 weeks; the community-reported acceptance is “11%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Gene Expression?
According to the journal's author guidelines: Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index Gene Expression?
According to LetPub and DOAJ records, Gene Expression is indexed in Scopus.
Is Gene Expression open access, and what is the APC?
Gene Expression is a fully open-access journal. APC about USD 980.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .